Hui Yao

2.2k total citations
32 papers, 1.6k citations indexed

About

Hui Yao is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Hui Yao has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cancer Research, 19 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Hui Yao's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Cancer, Lipids, and Metabolism (6 papers). Hui Yao is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Cancer, Lipids, and Metabolism (6 papers). Hui Yao collaborates with scholars based in China, United States and Australia. Hui Yao's co-authors include Guangchun He, Xiyun Deng, Rajyalakshmi Luthra, Shichao Yan, Liujiang Song, Chao Chen, Thomas J. Rosol, Rajesh R. Singh, Ronald Abraham and Angela Romans and has published in prestigious journals such as Nature Communications, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Hui Yao

30 papers receiving 1.6k citations

Peers

Hui Yao

ONCOL

PRM

SURGE

Marta Castiglia Italy

Irene V. Bijnsdorp Netherlands

Milind Suraokar United States

Ximing Xu China

Arran Turnbull United Kingdom

Chuangye Han China

Takaaki Masuda Japan

Ming Bai China

Tiansong Xia China

Rong Ma China

Marta Castiglia Italy

Hui Yao

608 ×0.6

730 ×0.8

619 ×1.7

ONCOL

518 ×1.5

PRM

93 ×0.8

SURGE

Citations per year, relative to Hui Yao Hui Yao (= 1×) peers Marta Castiglia

Countries citing papers authored by Hui Yao

Since Specialization

Citations

This map shows the geographic impact of Hui Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Yao more than expected).

Fields of papers citing papers by Hui Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Yao. The network helps show where Hui Yao may publish in the future.

Co-authorship network of co-authors of Hui Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Yao. A scholar is included among the top collaborators of Hui Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Yao. Hui Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Quan, Yuan Xie, Yan Zhang, et al.. (2025). Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy. Frontiers in Microbiology. 16. 1603671–1603671.

Yao, Hui, et al.. (2024). Azoxystrobin Exposure Impacts on Development Status and Physiological Responses of Worker Bees (Apis mellifera L.) from Larval to Pupal Stages. International Journal of Molecular Sciences. 25(21). 11806–11806. 3 indexed citations

Yao, Hui, Siyu Zhang, Yue Fan, et al.. (2023). RCN2 promotes Nasopharyngeal carcinoma progression by curbing Calcium flow and Mitochondrial apoptosis. Cellular Oncology. 46(4). 1031–1048. 9 indexed citations

Asare, Amma, Hui Yao, Olivia D. Lara, et al.. (2022). Race-associated Molecular Changes in Gynecologic Malignancies. Cancer Research Communications. 2(2). 99–109. 7 indexed citations

Deng, Hong, et al.. (2021). HES5 Activates Long Noncoding RNA UCA1 to Induce Colorectal Cancer Progression by Modulating miR-185/NOTCH3 Signaling. Gastroenterology Research and Practice. 2021. 1–12. 5 indexed citations

Zhang, Qiuting, Huimei Yi, Hui Yao, et al.. (2021). Artemisinin Derivatives Inhibit Non-small Cell Lung Cancer Cells Through Induction of ROS-dependent Apoptosis/Ferroptosis. Journal of Cancer. 12(13). 4075–4085. 99 indexed citations

Patel, Keyur P., Mark J. Routbort, Héctor M. Álvarez, et al.. (2021). Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing. Archives of Pathology & Laboratory Medicine. 145(11). 1405–1412. 9 indexed citations

Zheng, Chanjuan, Shichao Yan, Lu Lu, et al.. (2021). Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins. Frontiers in Oncology. 11. 656687–656687. 20 indexed citations

Yi, Huimei, Qiuting Zhang, Lu Lu, et al.. (2020). Reversal of HER2 Negativity: An Unexpected Role for Lovastatin in Triple-Negative Breast Cancer Stem Cells. Journal of Cancer. 11(13). 3713–3716. 10 indexed citations

10.

Chen, Xing-Xing, Jie Hu, Hui Yao, et al.. (2019). Inhibition of prostaglandin E2 receptor 4 by lnc000908 to promote the endothelial‐mesenchymal transition participation in cardiac remodelling. Journal of Cellular and Molecular Medicine. 23(9). 6355–6367. 6 indexed citations

11.

Zhang, Weijia, et al.. (2019). Poor expression of long-chain noncoding RNA GAPLINC inhibits epithelial–mesenchymal transition, and invasion and migration of hepatocellular carcinoma cells. Anti-Cancer Drugs. 30(8). 784–794. 5 indexed citations

12.

Yao, Hui, Dong Xia, Zonglin Li, et al.. (2018). MiR-382 functions as tumor suppressor and chemosensitizer in colorectal cancer. Bioscience Reports. 39(8). 26 indexed citations

13.

Lin, Hui, Zhiping Huang, Jiao Liu, et al.. (2018). MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN. Scientific Reports. 8(1). 10461–10461. 60 indexed citations

14.

Goswami, Rashmi S., Rajyalakshmi Luthra, Rajesh R. Singh, et al.. (2016). Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors. American Journal of Clinical Pathology. 145(2). 222–237. 90 indexed citations

15.

Yao, Hui, Guangchun He, Shichao Yan, et al.. (2016). Triple-negative breast cancer: is there a treatment on the horizon?. Oncotarget. 8(1). 1913–1924. 290 indexed citations

16.

Su, Xiaoping, Gabriel G. Malouf, Yunxin Chen, et al.. (2014). Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes. Oncotarget. 5(20). 9864–9876. 163 indexed citations

17.

Bartley, Angela N., Hui Yao, Bedia A. Barkoh, et al.. (2011). Complex Patterns of Altered MicroRNA Expression during the Adenoma-Adenocarcinoma Sequence for Microsatellite-Stable Colorectal Cancer. Clinical Cancer Research. 17(23). 7283–7293. 57 indexed citations

18.

Wang, Xiaojuan, Hongzhu Deng, Bin Jiang, & Hui Yao. (2011). The natural plant product sophocarpine ameliorates dextran sodium sulfate-induced colitis in mice by regulating cytokine balance. International Journal of Colorectal Disease. 27(5). 575–581. 27 indexed citations

19.

Luthra, Rajyalakshmi, Angela Romans, Ronald Abraham, et al.. (2010). Association of MicroRNA Expression with Microsatellite Instability Status in Colorectal Adenocarcinoma. Journal of Molecular Diagnostics. 12(4). 433–440. 148 indexed citations

20.

Maru, Dipen M., Rajesh R. Singh, Constance T. Albarracin, et al.. (2009). MicroRNA-196a Is a Potential Marker of Progression during Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus. American Journal Of Pathology. 174(5). 1940–1948. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact